Suppr超能文献

PTEN 和 Smad4 在小鼠唾液腺癌形成和进展中的相互作用。

Cooperation Between Pten and Smad4 in Murine Salivary Gland Tumor Formation and Progression.

机构信息

Laboratory of Precision Oncology, School of Pharmacy, China Medical University, Shenyang, Liaoning, China; Department of Otolaryngology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

Department of Oral Pathology, Dalian Medical University, Dalian, Liaoning, China.

出版信息

Neoplasia. 2018 Aug;20(8):764-774. doi: 10.1016/j.neo.2018.05.009. Epub 2018 Jun 27.

Abstract

Salivary gland tumor (SGT) is a rare tumor type, which exhibits broad-spectrum phenotypic, biological, and clinical heterogeneity. Currently, the molecular mechanisms that cause SGT pathogenesis remain poorly understood. A lack of animal models that faithfully recapitulate the naturally occurring process of human SGTs has hampered research progress on this field. In this report, we developed an inducible keratin 5-driven conditional knockout mouse model to delete gene(s) of interest in murine salivary gland upon local RU486 delivery. We have deleted two major tumor suppressors, Pten, a negative regulator of the PI3K pathway, and Smad4, the central signaling mediator of TGFβ pathway, in the murine salivary gland. Our results have shown that deletion of either Pten or Smad4 in murine salivary gland resulted in pleomorphic adenomas, the most common tumor in human SGT patients. Deletion of both Pten and Smad4 in murine salivary gland developed several malignancies, with salivary adenoid cystic carcinoma (SACC) being the most frequently seen. Molecular characterization showed that SACC exhibited mTOR activation and TGFβ1 overexpression. Examination of human SGT clinical samples revealed that loss of Pten and Smad4 is common in human SACC samples, particularly in the most aggressive solid form, and is correlated with survival of SACC patients, highlighting the human relevance of the murine models. In summary, our results offer significant insight into synergistic role of Pten and Smad4 in SGT, providing a rationale for targeting mTOR and/or TGFβ signaling to control SGT formation and progression.

摘要

唾液腺肿瘤 (SGT) 是一种罕见的肿瘤类型,表现出广泛的表型、生物学和临床异质性。目前,导致 SGT 发病机制的分子机制仍知之甚少。缺乏能够真实再现人类 SGT 自然发生过程的动物模型,阻碍了该领域的研究进展。在本报告中,我们开发了一种诱导型角蛋白 5 驱动的条件性敲除小鼠模型,可在局部 RU486 给药时在鼠唾液腺中删除感兴趣的基因。我们已经删除了两个主要的肿瘤抑制因子,PI3K 通路的负调节剂 Pten 和 TGFβ 通路的中央信号转导介质 Smad4,在鼠唾液腺中。我们的结果表明,在鼠唾液腺中删除 Pten 或 Smad4 均可导致多形性腺瘤,这是 SGT 患者最常见的肿瘤。在鼠唾液腺中同时删除 Pten 和 Smad4 可发展出多种恶性肿瘤,其中以腺样囊性癌 (SACC) 最为常见。分子特征表明 SACC 表现出 mTOR 激活和 TGFβ1 过表达。对人类 SGT 临床样本的检查表明,Pten 和 Smad4 的缺失在人类 SACC 样本中很常见,特别是在最具侵袭性的实体形式中,并且与 SACC 患者的生存相关,突出了这些小鼠模型与人类的相关性。总之,我们的结果为 Pten 和 Smad4 在 SGT 中的协同作用提供了重要的见解,为靶向 mTOR 和/或 TGFβ 信号来控制 SGT 的形成和进展提供了依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/921b/6031150/9e0121316830/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验